Previous close | 107.42 |
Open | 107.42 |
Bid | 109.70 |
Ask | 117.00 |
Strike | 520.00 |
Expiry date | 2024-06-21 |
Day's range | 107.42 - 107.42 |
Contract range | N/A |
Volume | |
Open interest | N/A |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.